Open AccessRuxolitinib and Severe COVID-19
Author(s) -
Rujittika Mungmunpuntipantip,
Viroj Wiwanitkit
Publication year - 2021
Publication title -
infection and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.724
H-Index - 26
eISSN - 2092-6448
pISSN - 1598-8112
DOI - 10.3947/ic.2021.0110
Subject(s) - medicine , ruxolitinib , covid-19 , virology , betacoronavirus , pandemic , coronavirus infections , intensive care medicine , outbreak , myelofibrosis , infectious disease (medical specialty) , bone marrow , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom